FDA Warns Companies for Illegally Selling Products With CBD

The US Food and Drug Administration (FDA) posted warning letters to five companies for illegally selling products containing cannabidiol (CBD).

“These companies are selling CBD-containing products that people may confuse for traditional foods or beverages, which may result in unintentional consumption or overconsumption of CBD. CBD-containing products in forms that are appealing to children, such as gummies, hard candies, and cookies, are especially concerning,” the FDA says.

Cannabidiol (CBD) is an active ingredient in the hemp plant which is not intoxicating. In recent years, CBD products, such as oils, sprays, and pills, have been gaining popularity in the US.

According to the FDA, the use of CBD raises safety concerns, especially with long-term use, as some studies suggest possible harm to the male reproductive system, the liver, and interactions to certain medications.

“The FDA has not found adequate information showing how much CBD can be consumed, and for how long, before causing harm,” the agency says.

Some studies suggest possible health benefits of CBD, such as relieving pain and inflammation, reducing anxiety, and improving sleep quality.

In addition, users report positive CBD effects. In a 2021 survey, 62.0% of participants reported trying a CBD product. Of those, more than half (59.0%) said these products have helped their pain and allowed them to reduce their pain medications (67.6%), including opioids (53.7%).